G. Gmelin

544 total citations
8 papers, 452 citations indexed

About

G. Gmelin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, G. Gmelin has authored 8 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in G. Gmelin's work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (2 papers). G. Gmelin is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (2 papers). G. Gmelin collaborates with scholars based in Netherlands, Germany and Switzerland. G. Gmelin's co-authors include Jan Malanowski, Albert Enz, René Amstutz, H. W. G. M. Boddeke, Annemarie Closse, José Palacios, Reinhold Tacke, Carsten Strohmann, E. Mutschler and Günter Lambrecht and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and Neuroscience Letters.

In The Last Decade

G. Gmelin

8 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Gmelin Netherlands	7	220	193	136	93	89	8	452
Jann A. Nielsen United States	9	223 1.0×	167 0.9×	172 1.3×	91 1.0×	91 1.0×	12	443
Jan Malanowski Germany	6	209 0.9×	108 0.6×	93 0.7×	72 0.8×	85 1.0×	10	390
Margaret E. Appleyard United Kingdom	12	279 1.3×	145 0.8×	158 1.2×	38 0.4×	64 0.7×	16	409
Yuka Kuriya Japan	8	319 1.4×	167 0.9×	156 1.1×	59 0.6×	87 1.0×	8	480
Kiyomi Yamatsu Japan	11	273 1.2×	208 1.1×	129 0.9×	205 2.2×	130 1.5×	23	619
Francis P. Huger United States	11	306 1.4×	226 1.2×	113 0.8×	335 3.6×	74 0.8×	29	684
Gina M. Bores United States	10	316 1.4×	184 1.0×	70 0.5×	246 2.6×	92 1.0×	15	531
Shawn B. Jones United States	4	193 0.9×	164 0.8×	86 0.6×	125 1.3×	121 1.4×	8	447
Anne‐Lie Svensson Sweden	12	389 1.8×	290 1.5×	181 1.3×	95 1.0×	108 1.2×	16	708
Joachim Hartmann Germany	14	215 1.0×	299 1.5×	153 1.1×	55 0.6×	93 1.0×	20	679

Countries citing papers authored by G. Gmelin

Since Specialization

Citations

This map shows the geographic impact of G. Gmelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gmelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gmelin more than expected).

Fields of papers citing papers by G. Gmelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Gmelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gmelin. The network helps show where G. Gmelin may publish in the future.

Co-authorship network of co-authors of G. Gmelin

This figure shows the co-authorship network connecting the top 25 collaborators of G. Gmelin. A scholar is included among the top collaborators of G. Gmelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Gmelin. G. Gmelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Enz, Albert, René Amstutz, H. W. G. M. Boddeke, G. Gmelin, & Jan Malanowski. (1993). Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Progress in brain research. 98. 431–438. 252 indexed citations

Shapiro, Gideon, Philipp Floersheim, René Amstutz, et al.. (1992). Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogs of pilocarpine and a hypothetical model for the binding of agonists to the M1 receptor. Journal of Medicinal Chemistry. 35(1). 15–27. 33 indexed citations

Shapiro, Gideon, Philipp Floersheim, René Amstutz, et al.. (1992). Muscarinic agonist SAR of azaspirodioxolanes. Bioorganic & Medicinal Chemistry Letters. 2(8). 815–820. 4 indexed citations

Lambrecht, Günter, et al.. (1988). o-Methoxy-sila-hexocyclium: a new quaternary M1-selective muscarinic antagonist. European Journal of Pharmacology. 151(1). 155–156. 18 indexed citations

Eltze, Manfrid, G. Gmelin, Jürgen Wess, et al.. (1988). Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. European Journal of Pharmacology. 158(3). 233–242. 50 indexed citations

Amstutz, René, Annemarie Closse, & G. Gmelin. (1987). Die Position 5 im Oxotremorin‐Gerüst: Eine zentrale Stelle für die Steuerung der Aktivität am muscarinischen Rezeptor. Helvetica Chimica Acta. 70(8). 2232–2244. 7 indexed citations

Palacios, José, et al.. (1986). The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist. European Journal of Pharmacology. 125(1). 45–62. 81 indexed citations

Frick, Willi, et al.. (1983). Muscarinic receptors on intact, cultured neurons. Characterization by [3H]quinuclidinylbenzilate binding. Neuroscience Letters. 40(1). 45–50. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact